Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jul 31;10(9):1438-1439.
doi: 10.1002/mdc3.13840. eCollection 2023 Sep.

Reply to: Disability Milestones and Death in Parkinson's Disease under Subthalamic Neurostimulation

Nils Schnalke  1   2 , Björn Falkenburger  1   2
Affiliations
Comment

Reply to: Disability Milestones and Death in Parkinson's Disease under Subthalamic Neurostimulation

Nils Schnalke et al. Mov Disord Clin Pract. .
No abstract available

Keywords: deep brain stimulation (DBS); morbidity milestones; neurodegeneration; neurofilament; nucleus subthalamicus (STN).

PubMed Disclaimer

Comment on

References

    1. Schnalke N, Konitsioti A, Frank A, et al. Morbidity milestones demonstrate long disability‐free survival in Parkinson's disease patients with deep brain stimulation of the subthalamic nucleus. Mov Disord Clin Pract 2023;10(4):569–578. 10.1002/mdc3.13698. - DOI - PMC - PubMed
    1. Mahlknecht P, Eisner W, Poewe W. Disability milestones and death in Parkinson's disease under subthalamic neurostimulation. Mov Disord Clin Pract 2023. Accepted Author Manuscript. 10.1002/mdc3.13841 - DOI - PMC - PubMed
    1. Kempster PA, O'Sullivan SS, Holton JL, Revesz T, Lees AJ. Relationships between age and late progression of Parkinson's disease: a clinico‐pathological study. Brain 2010;133(6):1755–1762. 10.1093/brain/awq059. - DOI - PubMed
    1. Ygland Rödström E, Mattsson‐Carlgren N, Janelidze S, Hansson O, Puschmann A. Serum Neurofilament light chain as a marker of progression in Parkinson's disease: long‐term observation and implications of clinical subtypes. J Parkinsons Dis 2022;12(2):571–584. 10.3233/JPD-212866. - DOI - PMC - PubMed
    1. Bendig J, Schnalke N, Klingelhoefer L, et al. Serum Neurofilament Predicts Mortality and Indicates Accelerated Neurodegeneration in Late‐Stage Parkinson's Disease; 2023; In Review. 10.21203/rs.3.rs-2821817/v1. - DOI - PMC - PubMed